Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis

被引：2
|
作者：
Perez-Ruixo, Juan-Jose [1 ]
Zhu, Yaowei [1 ]
Neyens, Martine [1 ]
Jouvin, Marie-Helene [1 ]
Ramchandren, Sindhu [1 ]
Xu, Yan [1 ]
Leu, Jocelyn [1 ]
Dosne, Anne-Gaelle [1 ]
Xiong, Yuan [1 ]
Valenzuela, Belen [1 ]
Ling, Leona [1 ]
Nandy, Partha [1 ]
Sun, Hong [1 ]
机构：
[1] Janssen Res & Dev, Raritan, NJ USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203877
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1-5.018
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study
    Vu, Tuan
    Druzdz, Artur
    Grosskreutz, Julian
    Habib, Ali A.
    Kaminski, Henry J.
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vissing, John
    Beau-Lejdstrom, Raphaelle
    Boehnlein, Marion
    Gasalla, Teresa
    Grimson, Fiona
    Tarancon, Thais
    Bril, Vera
    NEUROLOGY, 2023, 100 (17)
  • [32] Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study
    Antozzi, Carlo
    Vu, Tuan
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    Suzuki, Yasushi
    Youssef, Eriene
    Sanga, Panna
    Karcher, Keith
    Zhu, Yaowei
    Sheehan, John J.
    Sun, Hong
    LANCET NEUROLOGY, 2025, 24 (02): : 105 - 116
  • [33] Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis
    Tuan Vu
    Stephan Ortiz
    Masahisa Katsuno
    Djillali Annane
    Renato Mantegazza
    Kathleen N. Beasley
    Rasha Aguzzi
    James F. Howard
    Journal of Neurology, 2023, 270 : 3129 - 3137
  • [34] Causes of symptom dissatisfaction in patients with generalized myasthenia gravis
    Andersen, Linda Kahr
    Jakobsson, Anna Sofie
    Revsbech, Karoline Lolk
    Vissing, John
    JOURNAL OF NEUROLOGY, 2022, 269 (06) : 3086 - 3093
  • [35] LONG-TERM SAFETY AND EFFICACY OF NIPOCALIMAB IN GENERALIZED MYASTHENIA GRAVIS: VIVACITY-MG3 OPEN-LABEL INTERIM ANALYSIS
    Antozzi, Carlo
    Vu, Tuan
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    MUSCLE & NERVE, 2024, 70 (03) : 674 - 675
  • [36] NIPOCALIMAB, A NEW NEONATAL FRAGMENT CRYSTALLIZABLE BLOCKER, LEADS TO RAPID, SUBSTANTIAL AND SUSTAINED GENERALIZED MYASTHENIA GRAVIS DISEASE CONTROL
    Nowak, Richard
    Ait-Tihyaty, Maria
    Turkoz, Ibrahim
    Gandhi, Kavita
    Rodriguez, Rachelle
    Pease, Sheryl
    Gingerich, Sarah
    Katzberg, Hans
    MUSCLE & NERVE, 2024, 70 (03) : 707 - 707
  • [37] EFFECT OF ADMINISTRATION OF ACTH IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    NAMBA, T
    SILVERST.JN
    GROB, D
    JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (06): : 1051 - &
  • [38] Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis
    Monteleone, Jonathan P. R.
    Gao, Xiang
    Kleijn, Huub Jan
    Bellanti, Francesco
    Pelto, Ryan
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [39] MUSCLE STRENGTH AND FATIGUE IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Symonette, Caitlin J.
    Watson, Bradley V.
    Koopman, Wilma J.
    Nicolle, Michael W.
    Doherty, Timothy J.
    MUSCLE & NERVE, 2010, 41 (03) : 362 - 369
  • [40] Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis
    Vu, Tuan
    Ortiz, Stephan
    Katsuno, Masahisa
    Annane, Djillali
    Mantegazza, Renato
    Beasley, Kathleen N.
    Aguzzi, Rasha
    Howard, James F.
    JOURNAL OF NEUROLOGY, 2023, 270 (06) : 3129 - 3137
12345